DDB2 Antibodies

Santa Cruz Biotechnology provides a broad selection of DDB2 monoclonal antibodies for research focused on understanding DDB2 protein functions. DDB2 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DDB2, or Damage-specific DNA-binding protein 2, plays a critical role in the nucleotide excision repair pathway, which is essential for the removal of DNA lesions caused by UV radiation and other environmental factors. By recognizing and binding to damaged DNA, DDB2 facilitates the recruitment of repair proteins, ensuring genomic stability and cellular integrity. The study of DDB2 is vital for understanding mechanisms of DNA repair and implications of DNA damage in various diseases, including cancer. DDB2 monoclonal antibodies enable detailed analysis of protein expression patterns and interactions in different cellular compartments. Researchers can utilize DDB2 monoclonal antibodies to investigate protein localization, expression levels, and molecular interactions in various experimental settings. DDB2 monoclonal antibodies support cutting-edge research in DNA repair mechanisms, cancer biology, and cellular responses to environmental stress. Santa Cruz Biotechnology monoclonal antibodies continue to support researchers worldwide in advancing scientific understanding of DNA repair pathways and their impact on human health.